Paul D. Aubert - 30 Jul 2024 Form 4 Insider Report for BIO-PATH HOLDINGS, INC. (BPTH)

Reporting relationship: Director
Issuer ticker: BPTH
Reported as of: 30 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Aug 2024, 18:10:56 UTC
Prior SEC filing: 04 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Paul D. Aubert

Key filing fact

Paul D. Aubert filed Form 4 for BIO-PATH HOLDINGS, INC. (BPTH) on 01 Aug 2024.

Key facts

This page summarizes Paul D. Aubert's Form 4 filing for BIO-PATH HOLDINGS, INC. (BPTH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Aug 2024, 18:10.

Change

Previous filing in this sequence was filed on 04 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BPTH transaction Derivative

Common Stock Option (right to buy)

Award

Transaction value: $0
Shares: +2,000
Change %
Price: $0.000000
Shares after: 2,000
Date: 30 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000
Exercise price: $1.55
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 2,000 shares, based on continuing service to Bio-Path Holdings, Inc.